Arbutus Biopharma (ABUS) Receivables - Other (2010 - 2018)

Arbutus Biopharma (ABUS) has reported Receivables - Other for 9 consecutive years, with $128000.0 the latest figure, recorded in Q1 2018.

• Quarterly Receivables - Other changed 0.0% year-over-year to $128000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $128000.0 (changed 0.0% YoY) and the FY2017 annual result came in at $128000.0, changed 0.0% from the prior year.
• Receivables - Other held at $128000.0 in Q1 2018 per ABUS's latest filing, from $128000.0 in the prior quarter.
• Over the last five years, Receivables - Other for ABUS reached as high as $1.6 million in Q1 2015 and fell as low as $128000.0 in Q4 2015.
• A 5-year average of $291411.8 and a median of $128000.0 in 2015 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2014 — Receivables - Other surged 249602.92% — and 2016, when it slumped 91.97%.
• Year by year, Receivables - Other stood at $538000.0 in 2014, then plunged by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
• According to Business Quant data, Receivables - Other over the past three periods registered $128000.0, $128000.0, and $128000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.